Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares Rare cancers, CTLA-4, Ipilimumab, Skin cancer (all types) and the tags skin, rare.
Shares BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors, Sandra P. D'Angelo, TCR-T cell therapy, p53 / RB / cell-cycle checkpoint and the tag rare.
Shares Avelumab, Rare cancers, PD-1 / PD-L1 immune checkpoint & T-cell activation, Pfizer (incl. Seagen) and the tag rare.
Shares Rare cancers, Immune-related adverse events (irAEs), Tumour mutational burden (TMB), Pfizer (incl. Seagen) and the tag rare.
Shares Platinum + etoposide (EP / CE), Rare cancers, Nivolumab, PD-1 and the tag rare.
Shares Tumour virus research, UPMC Hillman Cancer Center, Oncogenic viruses, Immune-related adverse events (irAEs) and the tag skin.
Shares Rare cancers, p53 / RB / cell-cycle checkpoint, Merck & Co. (MSD), PD-1 and the tag rare.
Shares Oncogenic viruses, PD-1, IMRT / IGRT (modern external beam), Pembrolizumab and the tag rare.
The same record for scripts and assistants; checked 2026-09-08. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.